This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.
Nature cancer · 2026
Limited diagnostic utility of bone marrow sampling in PET-defined limited-stage follicular lymphoma.
British journal of haematology · 2026
Real-World Selection of Venetoclax-Obinutuzumab Versus BTK Inhibitor Therapy for Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
European journal of haematology · 2026
Latest funding
- $2,796,075
A Phase I Feasibility and Safety Study of GCAR1, a Chimeric Antigen Receptor (CAR) T-cell Therapy for Patients with Relapsed/Refractory GPNMB-Expressing Solid Tumors
CIHR · 2023 · Nominated PI
- $3,216,843
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
CIHR · 2022 · Co-investigator
- $804,211
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
CIHR · 2022 · Co-investigator
37 publications.
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.
Zemp FJ, Breckenridge Z, Song H, Gill GS, Louie TL, Narta K, Liu H, Suh Y, Guignard L, Mandujano-Tinoco EA, Collao N, Pyczek J, Ellestad KK, Curry J, Langley J, John C, Mah LK, Rajwani J, Evseev D, Turk M, Benaoudia S, Alex J, Naumenko V, Manoharan VT, Mehrabadi MK, Smith HA, Gilbert GNY, Gillmor A, Verhey TB, Todesco HM, Osz K, Ahn BY, Bogossian A, Anderson C, Sikdar S, Rukunuddin S, Bismar TA, Heng DYC, Lawson K, Linehan WM, Pedersen H, Gordon PMK, McIntyre JB, MacGregor J, Garzia L, Brodeur-Robb K, DiFrancesco L, Ogilvie T, Schöffski P, Wozniak A, Holt RA, Bell J, Senger DL, Lewis V, Monument M, Khan O, Baudrier L, Billon P, Gabriel V, Biernaskie J, Potts K, Trpkov K, Hay K, Quizi J, Chan J, Saleh R, Henning JW, Prokopishyn NL, Shafey M, Morrissy AS, Mahoney DJ
Limited diagnostic utility of bone marrow sampling in PET-defined limited-stage follicular lymphoma.
Solow M, Owen C, Stewart C, Cao JQ, Balogh A, Perry S, Shafey M, Street L, Puckrin R
Real-World Selection of Venetoclax-Obinutuzumab Versus BTK Inhibitor Therapy for Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Tidswell R, Owen C, Shafey M, Perry S, Cox-Kennett N, Sterrett R, Peters A, Puckrin R
Outcomes of Hematopoietic Cell Transplantation in Patients with Plasmablastic Lymphoma.
Al-Juhaishi T, Ahn KW, Chen T, Patel KK, Patel J, Herrera AF, Turtle CJ, Rizzo JD, Khimani F, Awan FT, Gibran-Nunes F, Ahmed G, Baird J, Lekakis LJ, Shadman M, Shafey M, Reidell PA, Merryman RW, Hamadani M, Ahmed S
Quality of Life and Comorbidities of Long-Term Survivors of Allogeneic Hematopoietic Cell Transplant Versus Their Siblings.
O'Sullivan DE, Blosser N, Crisp N, Randhawa B, Bista S, Beda G, Shafey M, Hay K, Puckrin R, Daly A, Storek J, Jamani K
Real-world eligibility, utilization, and barriers to CAR T-cell therapy in relapsed/refractory mantle cell lymphoma.
Puckrin R, Sapon-Cousineau V, Peters A, Owen C, Shafey M
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in Canada.
Lemieux C, Kuruvilla J, Shafey M, Davison K, Paulson K, Li SZL, Billen L, Nissen F, Wang HL, Kim JJ, Lee G, Hu ZH, Logan B, Feng Z, Pasquini MC, Hay K
Gaucher Disease Treated With Lentiviral-Mediated Gene Therapy: First Case.
Shafey M, Prokopishyn N, Khan A
Improving Patient Access through Value-Based CAR T Delivery: Examples Using a Micro-costing Tool.
Shafey M, Dickinson O, Lilley H, Doble B
Assessing the impact of aprepitant on response to dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP).
Thai K, Jupp J, Dersch-Mills D, Ghosh S, Shafey M, Fong L
A Phase I Feasibility and Safety Study of GCAR1, a Chimeric Antigen Receptor (CAR) T-cell Therapy for Patients with Relapsed/Refractory GPNMB-Expressing Solid Tumors
Principal investigators: Shafey, Mona; Abdul Razak, Albiruni R; Hay, Kevin A; Henning, Jan-Willem; Kekre, Natasha; Mahoney, Douglas J; Morrissy, Sorana A; Noujaim, Jonathan; Simmons, Christine E
Keywords: Alveolar Soft Part Sarcoma; Car T; Immunotherapy; Renal Cell Carcinoma; Sarcoma; Triple-Negative Breast Cancer
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
Principal investigators: Kekre, Natasha; Bredeson, Christopher; Hawrysh, Terry A; Fergusson, Dean A; Hay, Kevin A; Holt, Rob; Quizi, Jennifer L; Thavorn, Kednapa
Keywords: Access To Care; Car-T; Leukemia; Point-Of-Care Biomanufacturing
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
Principal investigators: Kekre, Natasha; Bredeson, Christopher; Hawrysh, Terry A; Fergusson, Dean A; Hay, Kevin A; Holt, Rob; Quizi, Jennifer L; Thavorn, Kednapa
Keywords: Access To Care; Car-T; Leukemia; Point-Of-Care Biomanufacturing
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Na Li and Na Li: 46 shared papers
- Mona Shafey and Kevin Hay: 4 shared papers
- John Kuruvilla and Mona Shafey: 3 shared papers
- Nizar Bahlis and Mona Shafey: 2 shared papers
- Na Li and Tyler Williamson: 1 shared paper
- Na Li and Mona Shafey: 1 shared paper
- Kylie Lepic and Mona Shafey: 1 shared paper
- Kylie Lepic and Jolanta Karpinski: 1 shared paper
- John Bell and Jennifer Chan: 1 shared paper
- John Bell and Michael Monument: 1 shared paper
- John Bell and Livia Garzia: 1 shared paper
- John Bell and Ramy Saleh: 1 shared paper
- John Bell and Jennifer Quizi: 1 shared paper
- John Bell and Victor Lewis: 1 shared paper
- John Bell and Mona Shafey: 1 shared paper
- John Bell and Kevin Hay: 1 shared paper
- John Bell and Pierre Billon: 1 shared paper
- Jennifer Chan and Michael Monument: 1 shared paper
- Jennifer Chan and Livia Garzia: 1 shared paper
- Jennifer Chan and Ramy Saleh: 1 shared paper
- Jennifer Chan and Jennifer Quizi: 1 shared paper
- Jennifer Chan and Victor Lewis: 1 shared paper
- Jennifer Chan and Mona Shafey: 1 shared paper
- Jennifer Chan and Kevin Hay: 1 shared paper
- Jennifer Chan and Pierre Billon: 1 shared paper
- Tyler Williamson and Na Li: 1 shared paper
- Tyler Williamson and Mona Shafey: 1 shared paper
- Michael Monument and Livia Garzia: 1 shared paper
- Michael Monument and Ramy Saleh: 1 shared paper
- Michael Monument and Jennifer Quizi: 1 shared paper
- Michael Monument and Victor Lewis: 1 shared paper
- Michael Monument and Mona Shafey: 1 shared paper
- Michael Monument and Jan-Willem Henning: 1 shared paper
- Michael Monument and Pierre Billon: 1 shared paper
- Livia Garzia and Mona Shafey: 1 shared paper
- John Kuruvilla and Kevin Hay: 1 shared paper
- Na Li and Mona Shafey: 1 shared paper
- Ramy Saleh and Mona Shafey: 1 shared paper
- Ramy Saleh and Jan-Willem Henning: 1 shared paper
- Jennifer Quizi and Mona Shafey: 1 shared paper
- Victor Lewis and Mona Shafey: 1 shared paper
- Nicole Prokopishyn and Mona Shafey: 1 shared paper
- Mona Shafey and Jan-Willem Henning: 1 shared paper
- Mona Shafey and Pierre Billon: 1 shared paper
- Mona Shafey and Jolanta Karpinski: 1 shared paper
- Medicine
- Community Health Sciences
- Pediatrics
- Hematology-Oncology
- Pathology and Laboratory Medicine
- Biochemistry, Microbiology and Immunology
- Department of Medicine
- Other
Co-authors at University of Calgary, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Kevin Hay
Medicine
4 shared papers, latest 2026
John Kuruvilla
Faculty
3 shared papers, latest 2026
Nizar Bahlis
Hematology-Oncology
2 shared papers, latest 2020
Jan-Willem Henning
Medicine
1 shared papers, latest 2013
Pierre Billon
Biochemistry and Molecular Biology
1 shared papers, latest 2026
Jolanta Karpinski
Department of Medicine
1 shared papers, latest 2021
John Bell
Biochemistry, Microbiology and Immunology
1 shared papers, latest 2026
Jennifer Chan
Pathology and Laboratory Medicine
1 shared papers, latest 2026
Tyler Williamson
Community Health Sciences
1 shared papers, latest 2013
Michael Monument
Surgery
1 shared papers, latest 2026
Livia Garzia
Faculty
1 shared papers, latest 2026
Na Li
Community Health Sciences
1 shared papers, latest 2023
Ramy Saleh
Medicine
1 shared papers, latest 2026
Jennifer Quizi
Faculty
1 shared papers, latest 2026
Victor Lewis
Pediatrics
1 shared papers, latest 2026
Na Li
Computing and Software
1 shared papers, latest 2023
Nicole Prokopishyn
Pediatrics
1 shared papers, latest 2026
Kylie Lepic
Oncology
1 shared papers, latest 2021
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.